Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
| ▸ | TOP2A | P11388 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | G6PC1 | P35575 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10321703 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL16353929 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL10321597 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL27112153 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL16353859 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL342149 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL10321022 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL16353930 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL10320909 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C19NR4A1MAOATOP2A | |
| SCHEMBL832504 | 0.98 | CYP1A2 (0.53) | CYP1A2CYP2C19NR4A1MAOATOP2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | claimed |
| US-11357708-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2022-06-14 | — | — | US | claimed |
| EP-3042645-B1 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2022-04-27 | — | — | EP | claimed |
| US-20180318178-A1 | DENTAL COMPOSITES WITH IMPROVED STORAGE STABILITY | IVOCLAR VIVADENT AG (LI) | 2018-11-08 | — | — | US | claimed |
| EP-3042645-A1 | Dental composites with improved storage stability | Ivoclar Vivadent AG (LI) | 2016-07-13 | — | — | EP | claimed |
| EP-4066902-B1 | ZWITTERIONIC COMPOUND AND PRODUCTION METHOD AND USE FOR SAME | UNIV TOKUSHIMA (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-12522678-B2 | Zwitterion compound and production method and use for same | TOKUSHIMA UNIVERSITY (JP) | 2026-01-13 | — | — | US | disclosed |
| US-20250213436-A1 | POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | disclosed |
| EP-4501974-A1 | POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, KIT FOR PREPARING CURABLE COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT AND DENTAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20250003961-A1 | BASE MATERIAL FOR MANUFACTURING SENSOR FOR ANALYZING DETECTION TARGET, SENSOR FOR ANALYZING DETECTION TARGET, METHOD FOR ANALYZING DETECTION TARGET | UNIV KOBE NAT UNIV CORP (JP) | 2025-01-02 | — | — | US | disclosed |
| US-12134089-B2 | Multimodal chromatographic media for protein separation | DIONEX CORPORATION | 2024-11-05 | — | — | US | disclosed |
| EP-1943278-A1 | POLYMERIZATION PROCESS WITH CATALYST REACTIVATION | CARNEGIE-MELLON UNIVERSITY (US) | 2008-07-16 | — | — | EP | disclosed |
| US-20070219330-A1 | Amide initiators | WARWICK EFFECT POLYMERS LIMITED (GB) | 2007-09-20 | — | — | US | disclosed |
| WO-2007083097-A1 | LIVING RADICAL POLYMERISATION PROCESS | WARWICK EFFECT POLYMERS LTD. (GB) | 2007-07-26 | — | — | WO | disclosed |
| EP-1784430-A1 | LIVING RADICAL POLYMERIZATION INITIATOR COMPRISING A FUNCTIONAL GROUP CAPABLE OF REACTING WITH POLYEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREWITH , POLYPEPTIDE CONJUGATES AND DRUGS OBTAINED THEREFROM. | Warwick Effect Polymers Limited (GB) | 2007-05-16 | — | — | EP | disclosed |
| WO-2007025310-A1 | POLYMERIZATION PROCESS WITH CATALYST REACTIVATION | CARNEGIE MELLON UNIVERSITY (US) | 2007-03-01 | — | — | WO | disclosed |
| EP-1646661-A2 | LIVING RADICAL POLYMERIZATION INITIATOR COMPRISING A FUNCTIONAL GROUP CAPABLE OF REACTING WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREWITH, POLYPEPTIDE CONJUGATES AND DRUNG OBTAINED THEREFROM | Warwick Effect Polymers Limited (GB) | 2006-04-19 | — | — | EP | disclosed |
| WO-2006003352-A1 | LIVING RADICAL POLYMERIZATION INITIATOR COMPRISING A FUNCTIONAL GROUP CAPABLE OF REACTING WITH POLYEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREWITH, POLYPEPTIDE CONJUGATES AND DRUGS OBTAINED THEREFROM | WARWICK EFFECT POLYMERS LIMITED (GB) | 2006-01-12 | — | — | WO | disclosed |
| WO-2004113394-A2 | LIVING RADICAL POLYMERIZATION INITIATOR COMPRISING A FUNCTIONAL GROUP CAPABLE OF REACTING WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREWITH, POLYPEPTIDE CONJUGATES AND DRUGS OBTAINED THEREFROM | WARWICK EFFECT POLYMERS LIMITED (GB) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213436-A1 | POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL | DNMT3L, CDK9, CDK6 | CYP1A2 4538/4885CYP2C19 3379/4885NR4A1 3589/4885 |
| US-12134089-B2 | Multimodal chromatographic media for protein separation | MAX, NEFM, MRPL21 | CYP1A2 4805/4885CYP2C19 4530/4885NR4A1 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.